Description
Indication & Scope
Truvada® Emtricitabine and Tenofovir Disoproxil Fumarate Tablets provides combination antiretroviral therapy for HIV-1 infection; pre-exposure prophylaxis for HIV prevention in high-risk populations.
- Mechanism: Two nucleoside reverse transcriptase inhibitors that together terminate HIV DNA chain elongation to block viral replication.
- Drug class: Fixed-combination dual nucleoside backbone antiretroviral agent for HIV treatment and prevention.
- Clinical use: Core backbone component for HIV combination therapy; daily oral pre-exposure prophylaxis to reduce HIV infection risk for exposed high-risk groups.
| Generic Name | Emtricitabine and Tenofovir Disoproxil Fumarate Tablets |
| Brand Name | Truvada |
| Ingredient | Emtricitabine and Tenofovir Disoproxil Fumarate |
| Dosage Form | Tablets |
| Package | Emtricitabine 200mg + Tenofovir Disoproxil Fumarate300mg*30 tablets/box |
| Conditions Treated | HIV-1 infection as part of combined regimens; HIV pre-exposure prophylaxis for high-risk populations |
| Taboos | Severe hypersensitivity to either active ingredient; confirmed HIV-positive status for prophylaxis use |
| Place of origin | 2100 Syntex Court, Mississauga, Ontario L5N 7K9 CANADA |
| Prescription type | Prescription-only |
| Storage Conditions | Sealed packs stored at 15°C–30°C, dry and protected from sunlight |
| Manufacturer | Patheon Inc. |
| Registration Authority | National Medical Products Administration (NMPA), China |
| Approval number | HJ20200025 |
| Approval Date | Apr 25, 2022 |
| Shelf Life | 30 months |
How to use ?
Recommended Dose: One combination tablet once daily for both treatment and prophylaxis indications.
Time: Fixed daily time, taken with or without meals.
Instructions for use: Never used as monotherapy for HIV treatment; strict daily adherence is required for effective pre-exposure prophylaxis; monitor renal function regularly long-term.
Interaction: Other renally cleared antivirals require dosage adjustment to prevent accumulation toxicity.
Side effects:
1. Common: mild headache, fatigue, nausea, diarrhea.
2. Rare severe: renal tubular injury, bone density reduction, lactic acidosis.
Important Notice
This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indicatiaon, and regional regulatory requirements.
Packaging & Shipping
Packaging
Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.
Shipping Methods
Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.
Export Support
Certificate of Analysis
GMP Certificate
Commercial Invoice
Packing List & CPP
Cold Chain Logistics
Customs Documentation
Scientific and regulatory sources
FAQ
What two completely separate approved uses apply to Emtricitabine and Tenofovir Disoproxil Fumarate Tablets antiretroviral tablet?
The medicine acts as a core component of HIV combination therapy and serves as daily pre-exposure prophylaxis for high-risk groups to prevent HIV infection.
Why can Emtricitabine and Tenofovir Disoproxil Fumarate Tablets never be used alone as full therapy for confirmed HIV-1 infection?
Monotherapy rapidly triggers HIV drug resistance, so the combination must always be paired with a third antiretroviral drug for treatment.
What long-term organ safety monitoring is required for continuous daily use of Emtricitabine and Tenofovir Disoproxil Fumarate Tablets?
Regular renal function testing is mandatory throughout long-term administration to detect early tubular injury.
What is the unified daily dosage for both the treatment and preventive indications of Emtricitabine and Tenofovir Disoproxil Fumarate Tablets?
One full combination tablet taken once daily serves as the standard dosage for both approved purposes.
Truvada® | Emtricitabine and Tenofovir Disoproxil Fumarate Tablets | HIV | DengYueRX
INN: Emtricitabine and Tenofovir Disoproxil Fumarate Tablets
Indications: HIV
Dosage Form: Tablets
Strength: Emtricitabine 200mg + Tenofovir Disoproxil Fumarate300mg/tablet
Original price was: $480.25.$408.21Current price is: $408.21.
